BCL2 and atherosclerosis: IL‐38 has been shown to inhibit apoptosis by upregulating Bcl‐2 and downregulating Bax, thereby enhancing the survival of vascular endothelial cells, reducing the apoptosis of smooth muscle cells and macrophages in the fibrous cap, and finally attenuating atherosclerosis.126, 137